Cargando…
MitoQ Modulates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction via Regulating Nrf2 Signaling
BACKGROUND: Gut barrier dysfunction with alterant mucosal permeability during sepsis is a challenge problem in clinical practice. Intestinal epithelial cells (IECs) are strongly involved in mucosal oxidative stress and inflammatory response. The current study aimed at investigating the effect of Mit...
Autores principales: | Zhang, Shengfeng, Zhou, Qingniao, Li, Youcheng, Zhang, Yunli, Wu, Yinmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171662/ https://www.ncbi.nlm.nih.gov/pubmed/32351320 http://dx.doi.org/10.1155/2020/3276148 |
Ejemplares similares
-
MitoQ Is Able to Modulate Apoptosis and Inflammation
por: Piscianz, Elisa, et al.
Publicado: (2021) -
Anthracycline-Induced Vascular Dysfunction: Is MitoQ the Answer?
por: Sawyer, Douglas B.
Publicado: (2020) -
The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway
por: Hu, Qiongyuan, et al.
Publicado: (2018) -
MitoQ protects against hyperpermeability of endothelium barrier in acute lung injury via a Nrf2-dependent mechanism
por: Cen, Mengyuan, et al.
Publicado: (2021) -
MitoQ improves mitochondrial dysfunction in heart failure induced by pressure overload
por: Ribeiro Junior, Rogério Faustino, et al.
Publicado: (2018)